A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.
The FDA recently confirmed that a new rule requiring healthcare providers to notify patients of their breast density status will be released in late 2022 or early 2023.
The new guidelines address issues with false negatives and positives from POC testing for fertility and reproductive health.